Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-01-02 @ 3:19 PM
Study NCT ID:
NCT06732232
Status:
RECRUITING
Last Update Posted:
2024-12-13
First Post:
2024-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Sponsor:
Shanghai Cell Therapy Group Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BZE2204-B-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None